Patrick Cramer
Direktor/Vorstandsmitglied bei WACKER CHEMIE AG
Profil
Mr. Patrick Cramer is a President at Max Planck Gesellschaft zur Förderung der Wissenschaften eV.
He is on the Board of Directors at Wacker Chemie AG and Max-Delbrück-Centrum für Molekulare Medizin (MDC).
Mr. Cramer was previously employed as a Professor by Ludwig-Maximilians-Universität München.
He also served on the board at Max Planck Institute For Multidisciplinary Sciences, Max Planck Institute For Biophysical Chemistry and Gene Center Munich.
He received his doctorate degree from Ruprecht-Karls-Universität Heidelberg.
Aktive Positionen von Patrick Cramer
| Unternehmen | Position | Beginn |
|---|---|---|
| WACKER CHEMIE AG | Direktor/Vorstandsmitglied | 01.01.2023 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Direktor/Vorstandsmitglied | - |
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
 Max Planck Gesellschaft zur Förderung der Wissenschaften eV Investment Trusts/Mutual FundsMiscellaneous Max Planck Gesellschaft zur Förderung der Wissenschaften eV (MPG) is a non-profit organization headquartered in Munich, Germany. The firm was founded in 1948 as a successor organization to the Kaiser Wilhelm Society. MPG conducts basic research in the natural sciences, life sciences, and humanities and provides investment advisory services to foundations. | Präsident | 22.06.2023 |
| University of Gottingen | Corporate Officer/Principal | 01.01.2017 |
Ehemalige bekannte Positionen von Patrick Cramer
| Unternehmen | Position | Ende |
|---|---|---|
| Max Planck Institute For Biophysical Chemistry | Direktor/Vorstandsmitglied | 01.01.2021 |
| Ludwig-Maximilians-Universität München | Corporate Officer/Principal | 01.01.2013 |
| Gene Center Munich | Direktor/Vorstandsmitglied | 01.01.2013 |
Ausbildung von Patrick Cramer
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| WACKER CHEMIE AG | Process Industries |
| Private Unternehmen | 3 |
|---|---|
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Commercial Services |
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
Max Planck Gesellschaft zur Förderung der Wissenschaften eV Investment Trusts/Mutual FundsMiscellaneous Max Planck Gesellschaft zur Förderung der Wissenschaften eV (MPG) is a non-profit organization headquartered in Munich, Germany. The firm was founded in 1948 as a successor organization to the Kaiser Wilhelm Society. MPG conducts basic research in the natural sciences, life sciences, and humanities and provides investment advisory services to foundations. | Miscellaneous |
| Gene Center Munich |
